Medindia

X

Joseph Cosgrove Named as E&Y Entrepreneur of the Year Finalist in the Greater Philadelphia Region

Tuesday, May 25, 2010 General News J E 4
Advertisement


PHILADELPHIA, May 24 Pentec Health Incorporated announced today that Joe Cosgrove, President and Chief Executive Officer, is a finalist for the Ernst & Young Entrepreneur of the YearŽ 2010 Award in the Greater Philadelphia Region. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their business and communities. Mr. Cosgrove was selected as a finalist from over 60 nominations by a panel of independent judges. Awards winners will be announced at a special gala event on June 9, 2010 at the Loews Hotel in Philadelphia.

"I'm very honored and humbled to be considered a finalist for this very prestigious award," stated Mr. Cosgrove. "My selection is recognition of the Company's performance and the outstanding efforts of all of our associates nationwide."

The Ernst & Young Entrepreneur of the Year awards program celebrates its 24th anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.

Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur of the Year national program. Award winners in several national categories as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California in November, 2010. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies.

About Pentec Health, Inc.

For more than 27 years, Pentec Health has been an industry leader in providing Specialty Infusion Services nationwide to patients who require access to complex pharmaceutical products and services outside of the hospital setting.

Based in Boothwyn, Pennsylvania, Pentec Health provides IPN and IDPN products and services to dialysis centers for their malnourished dialysis patients; and, as a Joint Commission accredited home care provider, offers specialty in-home infusion services for highly complex conditions that are underserved by traditional home care providers. Pentec Health offers preparation and clinical management of drug therapies, skilled nursing support, reimbursement services and unparalleled care coordination to patients with acute and chronic conditions.

Their "convenience of care" model is pharmacy based, nurse administered and patient and physician preferred.

Pentec Health is widely recognized as an organization with large scale efficiencies to meet all of their patients' Specialty Infusion needs, with the rapid responsiveness of a local provider.

About Ernst & Young's Entrepreneur Of The YearŽ Awards Program

Ernst & Young's Entrepreneur Of The YearŽ Award is the world's most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only true global award of its kind, the Ernst & Young Entrepreneur Of The YearŽ award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

Contact: Pentec Health, Inc Nora Brennan Tel: 484-480-2226

SOURCE Pentec Health, Inc
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Wellspring Hires Ravi Patel for SVP Strategy and A...
S
Alzheimer's Drug Discovery Foundation Funds Americ...